Average Co-Inventor Count = 6.60
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (13 from 3,923 patents)
2. Arrowhead Pharmaceuticals, Inc. (4 from 96 patents)
3. Ablynx N.v. (2 from 163 patents)
4. Arrowhead Research Corporation (1 from 18 patents)
20 patents:
1. 11208662 - RNAi inhibition of alpha-ENaC expression
2. 11111293 - IL-18 binding molecules
3. 10745473 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
4. 10544418 - RNAi inhibition of alpha-ENaC expression
5. 10544211 - TNF binders
6. 10081677 - IL-18 binding molecules
7. 10000561 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
8. 9914927 - RNAi inhibition of alpha-ENaC expression
9. 9745372 - TNF binders
10. 9476052 - RNAi inhibition of alpha-ENaC expression
11. 9376489 - IL-18 binding molecules
12. 9328174 - Chemokine receptor binding polypeptides
13. 9127067 - Methods of treatment using chemokine receptor binding polypeptides
14. 9074212 - RNAi inhibition of alpha-ENaC expression
15. 8591896 - Chemokine receptor binding polypeptides